Research focuses on: Delivery vehicles, controlled release, immunotherapeutics, immune-directing polymer coatings
The Wylie Lab develops protein-polymer conjugates for:
1. Delivery of biologics, primarily polymer-antibody conjugates, for applications in cancer immunotherapy and degenerative retinal diseases
2. Bioreactors to modulate blood chemistry towards the treatment of sepsis
3. Bio-inks for the 3D printing of tissues to improve drug screening efficiency
Please visit wylielab.com for more information.